Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials93
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review78
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a65
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis64
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin62
Neonatal ocular prophylaxis in the United States: is it still necessary?56
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex51
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis50
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies41
Challenges in preserving antibiotic effectiveness: time for a novel approach39
Visceral leishmaniasis elimination in India: progress and the road ahead37
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future37
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies35
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria35
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia34
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines34
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72032
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis28
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis27
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies26
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges26
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators24
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections22
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’22
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?22
0.066879987716675